Switzerland Infection Control Market - Forecasts from 2020 to 2025
Switzerland infection control market is projected to grow at a CAGR of 8.08% % to reach US$ 347.682 million by 2025. In Switzerland, 45% of the population who are employed are exposed to some sort of risk which is inclusive of but not limited to toxic products. In 2017, chronic hazardous drinking was observed among 5% of the population and 16% got drunk at least once a month. Further, in 2018 there were 425 new diagnoses of HIV. Further, the ratio between health expenditure and the gross domestic product (GDP) was to the tune of 12.4% in 2017, which in turn makes Switzerland a part of those European countries with the highest ratio and second after the USA the country that was leading in health expenditure in relation to GDP in 2017. Moreover, in 2017 households financed 65% of health expenditure; mandatory health insurance premiums from households covered 30% of health expenditure. Further, the government’s contribution to health expenditure was 29%, with over 6 in every 10 francs of this public funding correspond to payments from the cantons and communes to hospitals, nursing homes, and home care services. Additionally, the total health expenditure was 82,774 CHF million in 2017 [Source: Health Pocket Statistics 2019 Federal Statistics Office]. Thus, form the aforesaid, it is evident that there is a certain percent of the population that gets admitted to the hospitals and there are chances of getting admitted to the hospitals for the very nature of their work. This undoubtedly exposes them to the risk of contracting what The World Health Organization (WHO) defines as nosocomial infections. This requires infection prevention procedures to be even more stringent and rigorous. Further, with such a high ratio of health expenditure in relation to GDP, it is expected that all the aforementioned aspects will aid in propelling the growth of Switzerland's infection control market.
The rising awareness of adherence to hygienic processes the market for infection control in Switzerland is poised to grow at a healthy rate during the forecast period. Furthermore, as of 2017, the average disposable income per household per month was 6984 francs [Source: Federal Statistics Office]. Moreover, due to stringent regulatory compliance and inclusion of technically enhanced instruments there has been a growing need for advanced sterilizers that tailor-made for these devices which in turn is leading to more investment in research and development that has led to the growing adoption of low-temperature sterilizers with its wide range of technologies such as ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, and ozone gas-based sterilization. The other aspect along with those mentioned above that is also expected to throttle the infection control market trend of Switzerland upward is the burgeoning tourism sector which is the mainstay of the economy and necessitates the inclusion of hygienic process with regards to the food and beverage industry.
Segmentation
The rising awareness of adherence to hygienic processes the market for infection control in Switzerland is poised to grow at a healthy rate during the forecast period. Furthermore, as of 2017, the average disposable income per household per month was 6984 francs [Source: Federal Statistics Office]. Moreover, due to stringent regulatory compliance and inclusion of technically enhanced instruments there has been a growing need for advanced sterilizers that tailor-made for these devices which in turn is leading to more investment in research and development that has led to the growing adoption of low-temperature sterilizers with its wide range of technologies such as ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, and ozone gas-based sterilization. The other aspect along with those mentioned above that is also expected to throttle the infection control market trend of Switzerland upward is the burgeoning tourism sector which is the mainstay of the economy and necessitates the inclusion of hygienic process with regards to the food and beverage industry.
Segmentation
- By Product
- Disinfectants
- Sterilization
- Low-Temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End User Industry
- Healthcare
- Food and Beverage
- Chemical
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. SWITZERLAND INFECTION CONTROL MARKET, BY PRODUCT
5.1. Introduction
5.2. Disinfectants
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. SWITZERLAND INFECTION CONTROL MARKET, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. Belimed
8.2. DGM Infection Control Systems
8.3. SMEG
8.4. Steelco S.p.A.
8.5. Tuttnauer
8.6. List is not Exhaustive*
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. SWITZERLAND INFECTION CONTROL MARKET, BY PRODUCT
5.1. Introduction
5.2. Disinfectants
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. SWITZERLAND INFECTION CONTROL MARKET, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. Belimed
8.2. DGM Infection Control Systems
8.3. SMEG
8.4. Steelco S.p.A.
8.5. Tuttnauer
8.6. List is not Exhaustive*
